Knowledge of historical deal information is a crucial prerequisite for deal negotiations. PharmaDeal Financials are a series of unique therapeutic licensing databases providing insight into details of comparable deals, deal structures and deal trends. The databases feature deals over a 16 year period from a variety of companies, ranging from small company licensors to leading licensees like GlaxoSmithKline, Johnson & Johnson and Sanofi. Our proprietary databases distinguish themselves by focusing on specific disease areas, indications and/or compound classes and contain only licensing deals on therapeutics with at least one financial component. Each deal entry is categorized and searchable by licensor, licensee, indication, compound details, compound name, development stage (research – filed for regulatory approval), geographical territory, potential deal size, upfront, milestone payments (regulatory and sales), royalties on sales, research funding, equity and by year of deal establishment or any combination thereof. The databases can be downloaded directly on your desktop.

Available by PharmaPlus

• PharmaDeal Financials Autoimmune Disorders
• PharmaDeal Financials Cardiovascular Disorders
• PharmaDeal Financials CNS Disorders
• PharmaDeal Financials Infectious Diseases
• PharmaDeal Financials Metabolic Disorders
• PharmaDeal Financials Oncology
• PharmaDeal Financials Research Alliances
• PharmaDeal Financials Therapeutic Antibodies

We also offer a customized search service on deal financials according to specifications set by the client. For more information on our available databases and customized search service please visit the PharmaDeal Financials website.

Use of PharmaDeal Financials actually supported deal closure for clients that purchased the databases.